EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Nanosensitizer Potentiates Efficient Glioblastoma Gene-Radiotherapy through Synergistic Hypoxia Mitigation and PLK1 Silencing

Jiawei Chen, Jiajunzi Cui, Binbin Jiao, Ziyan Zheng, Haiwang Yu, Hanbing Wang, Guan Zhang, Shicong Lai, Zhihua Gan, Qingsong Yu iD

ACS Applied Materials & Interfaces · 30.10.2024 · 16 (43) · 58241-58261

DOI: 10.1021/acsami.4c11566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 17.09.2024. Verfasst von Jiawei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Organic-inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing…. Hauptthemen laut MEDLINE: Glioblastoma, Polo-Like Kinase 1, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Peking University Medicine Sailing Program for Young Scholars? Scientific & Technological Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsBiomimetic MaterialsCell Cycle ProteinsMicroRNAsAnimalsHumansMiceCell Line, TumorBrain NeoplasmsRadiation-Sensitizing AgentsMice, NudeGoldMetal NanoparticlesMice, Inbred BALB C

Stichwörter der Autor:innen

cell membrane camouflagegene therapyglioblastomahypoxia mitigationradiotherapy

Substanzen

Polo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsCell Cycle ProteinsMicroRNAsRadiation-Sensitizing AgentsGold

Autor:innen und Institutionen

  • The State Key Laboratory of Organic-inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
  • Department of Urology, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
  • Department of Urology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Department of Urology, Peking University People's Hospital, Beijing 100044, China.
  • The Institute of Applied Lithotripsy Technology, Peking University, Beijing 100044, China.

ORCID-Profile: Qingsong Yu

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Peking University Medicine Sailing Program for Young Scholars? Scientific & Technological Innovation
  • Peking University People?s Hospital

Zitieren

APA

Chen, J., Cui, J., Jiao, B., Zheng, Z., Yu, H., Wang, H., Zhang, G., Lai, S., Gan, Z., & Yu, Q. (2024). Biomimetic Nanosensitizer Potentiates Efficient Glioblastoma Gene-Radiotherapy through Synergistic Hypoxia Mitigation and PLK1 Silencing. ACS Applied Materials & Interfaces, 16(43), 58241-58261. https://doi.org/10.1021/acsami.4c11566

Vancouver

Chen J, Cui J, Jiao B, Zheng Z, Yu H, Wang H, et al. Biomimetic Nanosensitizer Potentiates Efficient Glioblastoma Gene-Radiotherapy through Synergistic Hypoxia Mitigation and PLK1 Silencing. ACS Applied Materials & Interfaces. 2024;16(43):58241-58261. doi:10.1021/acsami.4c11566

BibTeX
@article{Chen2024,
  author = {Chen, Jiawei and Cui, Jiajunzi and Jiao, Binbin and Zheng, Ziyan and Yu, Haiwang and Wang, Hanbing and Zhang, Guan and Lai, Shicong and Gan, Zhihua and Yu, Qingsong},
  title = {Biomimetic Nanosensitizer Potentiates Efficient Glioblastoma Gene-Radiotherapy through Synergistic Hypoxia Mitigation and PLK1 Silencing},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  volume = {16},
  number = {43},
  pages = {58241--58261},
  doi = {10.1021/acsami.4c11566}
}
Kostenlos starten →